MedTrace Logo

Comparison of Two Treatments for Post-Traumatic Stress Disorder

NCT00127673 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2022-05-24

Study results available
· View outcomes & findings →

Summary

This study will compare the short- and long-term effectiveness of two different treatments for people with post-traumatic stress disorder.

Conditions

  • Post-Traumatic Stress Disorder

Interventions

DRUG

Sertraline

The dose of sertraline will be up to 200 mg daily for 10 weeks. There will also be weekly meetings with study psychiatrist.

BEHAVIORAL

Cognitive behavioral therapy (CBT)

CBT will include 10 weekly sessions of individual cognitive behavioral therapy.

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Case Western Reserve University

    lead OTHER

Principal Investigators

  • Norah C. Feeny, PhD · Department of Psychology, Case Western Reserve University

  • Lori A. Zoellner, PhD · Department of Psychology, University of Washington

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-09-30
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00127673 on ClinicalTrials.gov